National Coverage Analysis (NCA)

Stem Cell Transplantation (Multiple Myeloma, Myelofibrosis, and Sickle Cell Disease)

CAG-00444R

Expand All | Collapse All

Documents

Contacts

CAG Resource Box
caginquiries@cms.hhs.gov
Lead Analysts
Lead Medical Officers

History of Considerations

History Title ID
First reconsideration Stem Cell Transplantation (Multiple Myeloma, Myelofibrosis, and Sickle Cell Disease) CAG-00444R You are here
Second reconsideration Autologous Stem Cell Transplantation (AuSCT) for Multiple Myeloma (MM) CAG-00444R2 View